Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00252226
Status:
COMPLETED
Last Update Posted:
2008-06-04
First Post:
2005-11-09
Brief Title:
Quetiapine Seroquel Maintenance Treatment in Early Onset Bipolar Spectrum Disorders
Sponsor:
Mood Disorders Center of Ottawa
Organization:
Mood Disorders Center of Ottawa
Study Overview
Official Title:
Quetiapine Seroquel Maintenance Treatment in Early Onset Bipolar Spectrum Disorders An Open Prospective Longitudinal Study of the Effectiveness of Quetiapine Monotherapy in Preventing Relapse and Minimizing Neurocognitive Dysfunction Among Adolescents Manifesting Bipolar Spectrum Disorders
Status:
COMPLETED
Status Verified Date:
2008-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single center open prospective study to evaluate the effectiveness of quetiapine monotherapy in the maintenance treatment of adolescent patients with a bipolar spectrum disorder bipolar I and bipolar II disorders cyclothymia and bipolar disorder not otherwise specified bipolar NOS for a minimum of 48 weeks Patients will be screened enrolment phase either when already stabilized or during an acute episode of maniahypomania or depression
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None